ALAMEDA - AgeX Therapeutics, Inc. ('AgeX'; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.
Balance Sheet Information
Cash, cash equivalents, and restricted cash totaled $0.3 million as of March 31, 2023. As of March 31, 2023, AgeX owed Juvenescence Limited $33.6 million in principal and origination fees on account of loans extended to AgeX.
Increase in Secured Note Line of Credit
On May 9, 2023, AgeX and Juvenescence entered into a second amendment to an Amended and Restated Secured Convertible Promissory Note (the 'Secured Note') to increase the amount of the line of credit available to AgeX by $4,000,000, subject to the terms of the Secured Note and Juvenescence's discretion to approve and fund each of AgeX's future draws of that additional amount of credit.
First Quarter 2023 Operating Results
Revenues: Total Revenues for the first quarter of 2023 were $10,000 as compared with $5,000 in the same period in 2022. Revenues are entirely comprised of sales of research products including stem cell products.
Operating expenses: Operating expenses for the three months ended March 31, 2023 were $2.2 million, as compared with $2.1 million for the same period in 2022.
Research and development expenses for the three months ended March 31, 2023 decreased by approximately $0.2 million to $0.2 million from $0.4 million during the same period in 2022. The net decrease was primarily attributable to reductions of $0.1 million in salaries to employees and related payroll related expenses, including noncash stock-based compensation expense, and general laboratory supplies and expenses, and $0.1 million in outside research and services allocable to research and development expenses.
General and administrative expenses for the three months ended March 31, 2023 increased by $0.3 million to $2.0 million as compared to $1.7 million during the same period in 2022. The net increase is attributable to increases of $0.5 million in professional fees for legal services and consulting expenses incurred in connection with due diligence and other expenses related to the possible merger between AgeX and Serina Therapeutics Inc., an Alabama corporation ('Serina'), and $0.1 million in professional fees for other non-recurring legal services. These increases were offset to some extent by a $0.2 million decrease in noncash stock-based compensation to employees, consultants and directors, and $0.1 million in patent and license maintenance related fees.
Other expense, net: Net other expense for the three months ended March 31, 2023 is comprised of $1.1 million amortization of deferred debt issuance costs and other debt related expenses included in interest expense and $30,000 unrealized loss on change in fair value of warrants issued to Juvenescence in connection with borrowings under loans from Juvenescence.
Net loss attributable to AgeX: The net loss attributable to AgeX for the three months ended March 31, 2023 was $3.3 million, or ($0.09) per share (basic and diluted) compared to $2.7 million, or ($0.07) per share (basic and diluted), for 2022. Increased net loss attributable to AgeX for the three months ended March 31, 2023 as compared to 2022 is largely attributable to expenses related to the possible merger between AgeX and Serina incurred in 2023 and increased amortization of deferred debt costs on loans from Juvenescence.
Going Concern Considerations
As required under Accounting Standards Update 2014-15, Presentation of Financial Statements-Going Concern (ASC 205-40), AgeX evaluates whether conditions and/or events raise substantial doubt about its ability to meet its future financial obligations as they become due within one year after the date its financial statements are issued. Based on AgeX's most recent projected cash flows, AgeX believes that its cash and cash equivalents and available sources of debt and equity capital including the loan facilities provided by Juvenescence to advance up to an additional $4 million to AgeX as of May 9, 2023 would not be sufficient to satisfy AgeX's anticipated operating and other funding requirements for the twelve months following the filing of AgeX's Quarterly Report on Form 10-Q for the three months ended March 31, 2023. These factors raise substantial doubt regarding the ability of AgeX to continue as a going concern.
About AgeX Therapeutics
AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics to treat human diseases to increase healthspan and combat the effects of aging. AgeX's PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeX's revolutionary longevity platform induced tissue regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. HyStem is AgeX's delivery technology to stably engraft PureStem or other cell therapies in the body. AgeX is seeking opportunities to establish licensing and collaboration arrangements around its broad IP estate and proprietary technology platforms and therapy product candidates.
Forward-Looking Statements
Certain statements contained in this release are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as 'will,' 'believes,' 'plans,' 'anticipates,' 'expects,' 'estimates' should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the 'Risk Factors' section of AgeX's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Contact:
Andrea E. Park
Email: apark@agexinc.com
Tel: (510) 671-8620
(C) 2023 Electronic News Publishing, source ENP Newswire
The rest is here:
AgeX Therapeutics Reports First Quarter 2023 Financial Results - Marketscreener.com
- Best Bill Farmer Films, Series and Shorts on Disney+ - What's On Disney Plus [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- Board of Ed Outlaws Native American Mascots in NY, What's Next ... - i95rock.com [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- Tooth Pari Series Review: Half-Witted Gore and Half-baked Lore With Vampires in Kolkata - FILM COMPANION [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- Fully Alive at the Easel: A Conversation with Michael Stevens (Part II) - Word on Fire [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- URI business professor, colleagues look at mortality and leadership ... - University of Rhode Island [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- Reflections: Resurrection hope - Wellington Advertiser [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- The X-Men's Nightcrawler is the Perfect Uncanny Spider-Man - CBR - Comic Book Resources [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- Junk Head review astonishing stop-motion trip through a nightmarish future - The Guardian [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- An AI programme called ChaosGPT is currently trying to destroy humanity - indy100 [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- The Quest for Human Immortality - Innovation & Tech Today [Last Updated On: April 20th, 2023] [Originally Added On: April 20th, 2023]
- Ranking of Kings: The Treasure Chest of Courage episode 5: Fren's rebellion to save Ouken, Whiteking's transformation, and Hokuro's devotion to Bojji... [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- 20 Underrated Movies with Huge Plot Twists - MovieWeb [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Plugged in and logged on: a history of the internet on film and TV - The Verge [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Salman Rushdie's Victory City Is A Prophetic Tale Of A Disruptor - India Currents [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- 'Gremlins: Secrets of the Mogwai' Review: An Adorable Expansion of ... - Collider [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Despite Terming Bottas as His Best Team Mate, Lewis Hamilton Became the Primary Reason Behind Valtteri Leaving Mercedes - EssentiallySports [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- In life and death: Colorful world of flowers and their meanings | Daily Sabah - Daily Sabah [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- How To Solve The Abacus Circuitry Puzzle In Honkai: Star Rail - Screen Rant [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Read the First Two Chapters of S.L. Huang's The Water Outlaws - tor.com [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- AIs Footsteps in Fiction: Classic Works That Portrayed the ... - Softonic EN [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Essential Reading: Books brimming with illuminating insights - ASU News Now [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Before the Legend: Remembering Secretariat's Magical 1973 Season - America's Best Racing [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Forget jobs will AI replace us? AI girlfriend you can speak with makes US$72,000 in a week - Vulcan Post [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Hell's Paradise: The Criminal Asaemon Pair With Deepens the Story - CBR - Comic Book Resources [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Why Hells Paradise manga has the perfect ending? - Dexerto [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Jamie Benn Is Still Here - D Magazine [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Three Ways to Be a Smarter Person | by umair haque | May, 2023 - Eudaimonia and Co [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- 5 Guinness World Records held by Kenya - Pulse Live Kenya [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- Deadpool Is About to Lose His Mind Like Never in Marvel History - Screen Rant [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- 'I could be hit by a bus tomorrow': Tom Hanks plans to continue his ... - We Got This Covered [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- The Power of Sight in AMC's Interview with the Vampire - tor.com [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- COMMUNITY VOICE: Another bogeyman to keep you awake at night - YourGV.com [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- The Fountain of Youth: Safe and Effective Anti-Aging Treatments for ... - The Medicine Maker [Last Updated On: May 18th, 2023] [Originally Added On: May 18th, 2023]
- July 10: Our Venerable Father Anthony of the Monastery of the ... - Edmonton Eparchy [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- The Naxos Quartet: The Greek Gods in the Modern World - Greek Reporter [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- All the New Sci-Fi, Fantasy, and Horror Books to Put on Your Radar for July - Yahoo Entertainment [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- Buhari: A legacy of indolence and parasites - TheCable [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- The NWT and immortality: Explore the North's cryonic burials - Cabin Radio [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- What Foods Contain Aspartame? What You Need to Know - Green Matters [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- Hilarious Giannis Antetokounmpo Jumps $174 Billion Brand to ... - The Sportsrush [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- Hell's Paradise: Who Are the Tensen & Why Are They so Powerful? - CBR - Comic Book Resources [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- Digital immortality, #DeathTok and the future of death - WGSN [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- Iterations of Immortality - Walter Bradley Center for Natural and Artificial Intelligence [Last Updated On: June 30th, 2023] [Originally Added On: June 30th, 2023]
- 10 Wolverine Villains The MCU Can Finally Introduce - Screen Rant [Last Updated On: October 27th, 2023] [Originally Added On: October 27th, 2023]
- 10 Best Horror Movies Based On Latin American Folklore - Screen Rant [Last Updated On: October 27th, 2023] [Originally Added On: October 27th, 2023]
- How to Read 'The Vampire Chronicles' In Order - Esquire [Last Updated On: October 27th, 2023] [Originally Added On: October 27th, 2023]
- Media Review: Rusty Lake The Etownian - Etownian [Last Updated On: October 27th, 2023] [Originally Added On: October 27th, 2023]
- Unlocking the Secrets of Immortality: Tardigrade Proteins Slow Aging in Human Cells - SciTechDaily [Last Updated On: April 2nd, 2024] [Originally Added On: April 2nd, 2024]